Metabolic plasticity and cancer stem cell metabolism: Exploring the glycolysis-OXPHOS switch as a mechanism for resistance and tumorigenesis

The Warburg Effect: How Does it Benefit Cancer Cells?

Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150 · see citing works

Why Do Cancers Have High Aerobic Glycolysis?

Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784 · see citing works

Metabolic reprogramming and cancer progression

Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020) · Science · doi:10.1126/science.aaw5473 · Cited by 2,740 · see citing works

Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions

Chen, Z., Han, F., Du, Y., Shi, H., & Zhou, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01332-8 · Cited by 1,612 · see citing works

Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function

Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. (2014) · Nature · doi:10.1038/nature13611 · Cited by 1,259 · see citing works

Cancer stem cells as key drivers of tumour progression

Ayob, A. Z., & Ramasamy, T. S. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0426-4 · Cited by 910 · see citing works

We need to talk about the Warburg effect

DeBerardinis, R. J., & Chandel, N. S. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0172-2 · Cited by 864 · see citing works

Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer

Dong, C., Yuan, T., Wu, Y., Wang, Y., Fan, T. W. ‐., Miriyala, S., Lin, Y., Yao, J., Shi, J., Kang, T., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.022 · Cited by 806 · see citing works

The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism

Lu, J., Tan, M., & Cai, Q. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.04.001 · Cited by 800 · see citing works

MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells

Sancho, P., Burgos-Ramos, E., Tavera, A., Bou Kheir, T., Jagust, P., Schoenhals, M., Barneda, D., Sellers, K., Campos-Olivas, R., Graña, O., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.015 · Cited by 722 · see citing works

The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment

Emami Nejad, A., Najafgholian, S., Rostami, A., Sistani, A., Shojaeifar, S., Esparvarinha, M., Nedaeinia, R., Haghjooy Javanmard, S., Taherian, M., Ahmadlou, M., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-020-01719-5 · Cited by 693 · see citing works

Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1

Kim, J.-W., Gao, P., Liu, Y.-C., Semenza, G. L., & Dang, C. V. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00440-07 · Cited by 658 · see citing works

Signal Transduction and Targeted Therapy

(2019) · Signal Transduction and Targeted Therapy · doi:10.1038/41392.2059-3635 · Cited by 613 · see citing works

Mechanisms and Implications of Metabolic Heterogeneity in Cancer

Kim, J., & DeBerardinis, R. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.013 · Cited by 606 · see citing works

Cancer stem cells: advances in knowledge and implications for cancer therapy

Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 598 · see citing works

Hallmarks of cancer stem cell metabolism

Sancho, P., Barneda, D., & Heeschen, C. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.152 · Cited by 577 · see citing works

Lactate in the tumour microenvironment: From immune modulation to therapy

Wang, Z.-H., Peng, W., Zhang, P., Yang, X., & Zhou, Q. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103627 · Cited by 547 · see citing works

Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target

Infantino, V., Santarsiero, A., Convertini, P., Todisco, S., & Iacobazzi, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115703 · Cited by 511 · see citing works

Cancer Stem Cell Metabolism

Peiris-Pagès, M., Martinez-Outschoorn, U. E., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0712-6 · Cited by 465 · see citing works

Regulation of cancer cell metabolism: Oncogenic MYC in the driver’s seat

Dong, Y., Tu, R., Liu, H., & Qing, G. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00235-2 · Cited by 405 · see citing works

Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment

Pérez‐Tomás, R., & Pérez-Guillén, I. (2020) · Cancers · doi:10.3390/cancers12113244 · Cited by 398 · see citing works

Modulating Glycolysis to Improve Cancer Therapy

Chelakkot, C., Chelakkot, V. S., Shin, Y. K., & Song, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032606 · Cited by 378 · see citing works

Metabolic Reprogramming of Cancer-Associated Fibroblasts by IDH3α Downregulation

Zhang, D., Wang, Y., Shi, Z., Liu, J., Sun, P., Hou, X., Zhang, J., Zhao, S., Zhou, B. P., & Mi, J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.006 · Cited by 334 · see citing works

The metabolic landscape of RAS-driven cancers from biology to therapy

Mukhopadhyay, S., Vander Heiden, M. G., & McCormick, F. (2021) · Nature Cancer · doi:10.1038/s43018-021-00184-x · Cited by 315 · see citing works

Metabolic reprogramming in cancer: Mechanisms and therapeutics

Nong, S., Han, X., Yu, X., Qian, Y., Wei, Y., Zhang, T., Tian, K., Shen, K., Yang, J., & Ma, X. (2023) · MedComm · doi:10.1002/mco2.218 · Cited by 300 · see citing works

Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation

Pastò, A., Bellio, C., Pilotto, G., Ciminale, V., Silic‐Benussi, M., Guzzo, G., Rasola, A., Frasson, C., Nardo, G., Zulato, E., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2010 · Cited by 293 · see citing works

Emerging therapies in cancer metabolism

Xiao, Y., Yu, T., Xu, Y., Ding, R., Wang, Y.-P., Jiang, Y., & Shao, Z. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.006 · Cited by 267 · see citing works

Tumor suppressor p53 and its mutants in cancer metabolism

Liu, J., Zhang, C., Hu, W., & Feng, Z. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.12.025 · Cited by 266 · see citing works

Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells

Luca, A. D., Fiorillo, M., Peiris‐Pagès, M., Ózsvári, B., Smith, D. L., Sánchez‐Alvarez, R., Martinez‐Outschoorn, U., Cappello, A. R., Pezzi, V., Lisanti, M. P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4401 · Cited by 262 · see citing works

Mitochondrial dynamics as regulators of cancer biology

Trotta, A. P., & Chipuk, J. E. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2451-3 · Cited by 220 · see citing works

High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant

Farnie, G., Sotgia, F., & Lisanti, M. P. (2015) · Oncotarget · doi:10.18632/oncotarget.5401 · Cited by 206 · see citing works

Cancer Stem Cell Metabolism and Potential Therapeutic Targets

Snyder, V., Reed-Newman, T. C., Arnold, L., Thomas, S. M., & Anant, S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00203 · Cited by 197 · see citing works

Cancer stem cell metabolism: target for cancer therapy

Chae, Y. C., & Kim, J. H. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.7.112 · Cited by 182 · see citing works

miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect

SUN, Y., Zhao, X., Zhou, Y., & Hu, Y. (2012) · Oncology Reports · doi:10.3892/or.2012.1958 · Cited by 169 · see citing works

LncRNA KCNQ1OT1 sponges miR-34c-5p to promote osteosarcoma growth via ALDOA enhanced aerobic glycolysis

Shen, Y., Xu, J., Pan, X., Zhang, Y., Weng, Y., Zhou, D., & He, S. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2485-1 · Cited by 150 · see citing works

The regulation of cellular metabolism by tumor suppressor p53

Liang, Y., Liu, J., & Feng, Z. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-9 · Cited by 147 · see citing works

Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling

Lamb, R., Bonuccelli, G., Ózsvári, B., Peiris‐Pagès, M., Fiorillo, M., Smith, D. L., Bevilacqua, G., Mazzanti, C. M., McDonnell, L. A., Naccarato, A. G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5852 · Cited by 145 · see citing works

Energy Metabolism Characterization of a Novel Cancer Stem Cell‐ L ike Line 3 AB ‐ OS

Palorini, R., Votta, G., Balestrieri, C., Monestiroli, A., Olivieri, S., Vento, R., & Chiaradonna, F. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24671 · Cited by 139 · see citing works

Cisplatin in Ovarian Cancer Treatment—Known Limitations in Therapy Force New Solutions

Zoń, A., & Bednarek, I. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087585 · Cited by 135 · see citing works

Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?

Lord, S., & Harris, A. L. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02204-2 · Cited by 132 · see citing works

Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the α-Ketoglutarate Signaling Pathway

Tseng, C.-W., Kuo, W., Chan, S., Chan, H., Chang, K., & Wang, L. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2906 · Cited by 131 · see citing works

The role of p53 in cell metabolism

Zhang, X., Qin, Z.-H., & Wang, J. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.151 · Cited by 128 · see citing works

Tumor Cells Switch to Mitochondrial Oxidative Phosphorylation under Radiation via mTOR-Mediated Hexokinase II Inhibition - A Warburg-Reversing Effect

Lu, C., Qin, L., Liu, H.-C., Candas, D., Fan, M., & Li, J. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121046 · Cited by 126 · see citing works

Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation

Li, T., Mao, C., Wang, X., Shi, Y., & Tao, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01733-5 · Cited by 125 · see citing works

The Anti-Warburg Effect Elicited by the cAMP-PGC1α Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes

Xing, F., Luan, Y., Cai, J., Wu, S., Mai, J., Gu, J., Zhang, H., Li, K., Lin, Y., Xiao, X., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.037 · Cited by 120 · see citing works

The metabolic modulator PGC-1α in cancer.

Bost, F., & Kaminski, L. (2019) · Europe PMC (PubMed Central) · Cited by 119 · see citing works

Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinoma

Li, L., Yang, L., Fan, Z., Xue, W., Shen, Z., Yuan, Y., Sun, X., Wang, D., Lian, J., Wang, L., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0152-8 · Cited by 110 · see citing works

Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes

Lunetti, P., Giacomo, M. D., Vergara, D., Domenico, S. D., Maffia, M., Zara, V., Capobianco, L., & Ferramosca, A. (2019) · FEBS Journal · doi:10.1111/febs.14756 · Cited by 104 · see citing works

Suppression of miR‐199a maturation by HuR is crucial for hypoxia‐induced glycolytic switch in hepatocellular carcinoma

Zhang, L., Lou, J., Lü, M., Gao, C., Zhao, S., Li, B., Liang, S., Li, Y., Li, D., & Liu, M. (2015) · The EMBO Journal · doi:10.15252/embj.201591803 · Cited by 99 · see citing works

miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors

Bacci, M., Giannoni, E., Fearns, A., Ribas, R., Gao, Q., Taddei, M. L., Pintus, G., Dowsett, M., Isacke, C. M., Martin, L., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2038 · Cited by 99 · see citing works

Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma

Liu, Z., Zhang, Z., Zhang, Y., Zhou, W., Zhang, X., Peng, C., Ji, T., Zou, X., Zhang, Z., & Ren, Z. (2024) · International Journal of Oral Science · doi:10.1038/s41368-023-00267-8 · Cited by 96 · see citing works

2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotype

O’Neill, S., Porter, R. K., McNamee, N., Martinez, V. G., & O’Driscoll, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-39789-9 · Cited by 93 · see citing works

HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells

Teng, R., Liu, Z., Tang, H., Zhang, W., Chen, Y., Xu, R., Chen, L., Song, J., Liu, X., & Deng, H. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101218 · Cited by 81 · see citing works

Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer

Sriramkumar, S., Sood, R., Huntington, T. D., Ghobashi, A. H., Vuong, T. T., Metcalfe, T. X., Wang, W., Nephew, K. P., & O’Hagan, H. M. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03447-y · Cited by 81 · see citing works

Ablation of CD44 induces glycolysis-to-oxidative phosphorylation transition via modulation of the c-Src–Akt–LKB1–AMPKα pathway

Nam, K., Oh, S., & Shin, I. (2016) · Biochemical Journal · doi:10.1042/bcj20160613 · Cited by 79 · see citing works

Epithelial–Mesenchymal Transition (EMT) Induced by TGF-β in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism

Soukupová, J., Malfettone, A., Bertrán, E., Hernández‐Álvarez, M. I., Peñuelas‐Haro, I., Dituri, F., Giannelli, G., Zorzano, A., & Fabregat, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115543 · Cited by 77 · see citing works

AMPK-dependent phosphorylation of HDAC8 triggers PGM1 expression to promote lung cancer cell survival under glucose starvation

Li, Y., Liang, R., Sun, M., Li, Z., Sheng, H., Wang, J., Xu, P., Liu, S., Yang, W., Lü, B., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.03.007 · Cited by 75 · see citing works

Glutamine deficiency promotes stemness and chemoresistance in tumor cells through DRP1-induced mitochondrial fragmentation

Prasad, P., Ghosh, S., & Roy, S. S. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03818-6 · Cited by 72 · see citing works

Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies

Amengual-Cladera, E., Morla-Barcelo, P. M., Morán-Costoya, A., Valle, A., Pons, D. G., Sastre‐Serra, J., Roca, P., & Nadal‐Serrano, M. (2024) · Biology · doi:10.3390/biology13050302 · Cited by 67 · see citing works

Altered glycolysis results in drug‑resistant in clinical tumor therapy (Review)

Peng, J., Cui, Y., Xu, S., Wu, X., Huang, Y., Zhou, W., Wang, S., Fu, Z., & Xie, H. (2021) · Oncology Letters · doi:10.3892/ol.2021.12630 · Cited by 67 · see citing works

Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines

Tataranni, T., Agriesti, F., Pacelli, C., Ruggieri, V., Laurenzana, I., Mazzoccoli, C., Sala, G. D., Panebianco, C., Pazienza, V., Capitanio, N., et al. (2019) · Cells · doi:10.3390/cells8050478 · Cited by 65 · see citing works

Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M., Lovinfosse, P., Durieux, F., Gofflot, S., Bellier, J., Costanza, B., Herfs, M. F., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0287-z · Cited by 64 · see citing works

HIF-1α-induced miR-23a∼27a∼24 cluster promotes colorectal cancer progression via reprogramming metabolism

Jin, F., Yang, R., Yao, W., Wang, D., Zhu, Y., Wang, X., Lu, Y., Wang, Y., Zen, K., & Li, L. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.025 · Cited by 61 · see citing works

S100A10 Accelerates Aerobic Glycolysis and Malignant Growth by Activating mTOR-Signaling Pathway in Gastric Cancer

Li, Y., Li, X., Li, L., Zhou, R., Sikong, Y., Gu, X., Jin, B.-Y., Li, B., Li, Y., & Zuo, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.559486 · Cited by 58 · see citing works

Lactate Rewrites the Metabolic Reprogramming of Uveal Melanoma Cells and Induces Quiescence Phenotype

Longhitano, L., Giallongo, S., Orlando, L., Broggi, G., Longo, A., Russo, A., Caltabiano, R., Giallongo, C., Barbagallo, I. A., Rosa, M. D., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010024 · Cited by 55 · see citing works

The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer

Liu, F., Zhang, W., You, X., Liu, Y., Li, Y., Wang, Z., Wang, Y., Zhang, X., & Ye, L. (2015) · Oncotarget · doi:10.18632/oncotarget.4508 · Cited by 46 · see citing works

MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer

Zhao, S., Zhang, X., Shi, Y., Lu, C., Song, T., Wu, B., Li, J., & Yang, H. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01802-9 · Cited by 44 · see citing works

SOX2 as a novel contributor of oxidative metabolism in melanoma cells

Andreucci, E., Pietrobono, S., Peppicelli, S., Ruzzolini, J., Bianchini, F., Biagioni, A., Stecca, B. A., & Calorini, L. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0297-z · Cited by 43 · see citing works

New insight into the role of metabolic reprogramming in melanoma cells harboring BRAF mutations

Ferretta, A., Maida, I., Guida, S., Azzariti, A., Porcelli, L., Tommasi, S., Zanna, P. T., Cocco, T., Guida, M., & Guida, G. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.08.007 · Cited by 38 · see citing works

Dichloroacetic acid upregulates apoptosis of ovarian cancer cells by regulating mitochondrial function

Zhou, L., Liu, L., Chai, W., Zhao, T., Jin, X., Guo, X., Han, L., & Yuan, C. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s194329 · Cited by 37 · see citing works

Targeting cancer stem cells from a metabolic perspective

Shen, Y., Pan, S.-C., Chu, I., Lai, R.-Y., & Wei, Y. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220909309 · Cited by 37 · see citing works

Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate

Dueregger, A., Schöpf, B., Eder, T., Hoefer, J., Gnaiger, E., Aufinger, A., Kenner, L., Perktold, B., Ramoner, R. E., Klocker, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135704 · Cited by 36 · see citing works

Hypoxia-regulated microRNAs: the molecular drivers of tumor progression

Sawai, S., Wong, P., & Ramasamy, T. S. (2022) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2022.2088684 · Cited by 35 · see citing works

Pyruvate dehydrogenase kinase 1 interferes with glucose metabolism reprogramming and mitochondrial quality control to aggravate stress damage in cancer

Deng, X., Wang, Q., Cheng, M., Chen, Y., Yan, X., Guo, R., Sun, L., Li, Y., & Liu, Y. (2019) · Journal of Cancer · doi:10.7150/jca.34330 · Cited by 34 · see citing works

Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers

Zhong, Y., Li, X., Ji, Y., Li, X., Li, Y., Yu, D., Yuan, Y., Liu, J., Li, H., Zhang, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14527 · Cited by 34 · see citing works

Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis

Greer, Y. E., Hernandez, L. F., Fennell, E. M. J., Kundu, M., Voeller, D. M., Chari, R., Gilbert, S. F., Gilbert, T. S. K., Ratnayake, S., Tang, B., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0142 · Cited by 33 · see citing works

Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells

Veyrat, M., Durand, S., Classe, M., Glavan, T. M., Oker, N., Kapetanakis, N.-I., Jiang, X., Gelin, A., Herman, P., Casiraghi, O., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12892 · Cited by 32 · see citing works

PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway

Wang, X., Duan, W., Li, X., Liu, J., Li, D., Ye, L., Lü, Q., Yang, A., Xu, Q., Liu, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5726 · Cited by 32 · see citing works

Intraperitoneal delivery of a novel liposome-encapsulated paclitaxel redirects metabolic reprogramming and effectively inhibits cancer stem cells in Taxol(®)-resistant ovarian cancer.

Shen, Y., Li, W.-H., Chen, P.-H., He, C.-L., Chang, Y.-H., & Chuang, C.-M. (2015) · Europe PMC (PubMed Central) · Cited by 28 · see citing works

Intraperitoneal 188Re-Liposome delivery switches ovarian cancer metabolism from glycolysis to oxidative phosphorylation and effectively controls ovarian tumour growth in mice

Shen, Y., Lan, K.-L., Chang, C. H., Lin, L., He, C. L., Chen, P. H., Lee, T. W., Lee, Y. J., & Chuang, C. M. (2016) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2016.02.007 · Cited by 28 · see citing works

Dual PPARγ/ɑ agonist oroxyloside suppresses cell cycle progression by glycolipid metabolism switch-mediated increase of reactive oxygen species levels

Zhou, Y., Guo, Y., Zhu, Y., Sun, Y., Li, W., Li, Z., & Wei, L. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.032 · Cited by 28 · see citing works

Cancer cells with high-metastatic potential promote a glycolytic shift in activated fibroblasts

Kogure, A., Naito, Y., Yamamoto, Y., Yashiro, M., Kiyono, T., Yanagihara, K., Hirakawa, K., & Ochiya, T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234613 · Cited by 27 · see citing works

ARRB1 Regulates Metabolic Reprogramming to Promote Glycolysis in Stem Cell-Like Bladder Cancer Cells

Mamouni, K., Kim, J., Lokeshwar, B. L., & Kallifatidis, G. (2021) · Cancers · doi:10.3390/cancers13081809 · Cited by 24 · see citing works

Glucose transporter-1 expression in CD133+ laryngeal carcinoma Hep-2 cells

CHEN, X.-H., Bao, Y., Zhou, S., Wang, Q., WEI, Y., & Fan, J. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1740 · Cited by 23 · see citing works

Monoamine Oxidase Inhibitors Prevent Glucose-Dependent Energy Production, Proliferation and Migration of Bladder Carcinoma Cells

Resta, J., Santin, Y., Roumiguié, M., Riant, É., Lucas, A., Couderc, B. C., Binda, C., Lluel, P., Parini, A., & Mialet‐Perez, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911747 · Cited by 17 · see citing works

Steroid Receptor Coactivator 1 is an Integrator of Glucose and NAD+/NADH Homeostasis

Motamed, M., Rajapakshe, K., Hartig, S. M., Coarfa, C., Moses, R. E., Lonard, D. M., & O’Malley, B. W. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1404 · Cited by 17 · see citing works

MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells

Yamashita, N., Withers, H. G., Morimoto, Y., Bhattacharya, A., Haratake, N., Daimon, T., Fushimi, A., Nakashoji, A., Thorner, A. R., Isenhart, E., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108168 · Cited by 14 · see citing works

Why Metformin Should Not Be Used as an Oxidative Phosphorylation Inhibitor in Cancer Patients

Sakellakis, M. (2023) · Chemotherapy · doi:10.1159/000531606 · Cited by 8 · see citing works

Anti-cancer effect of a novel 2,3-didithiocarbamate-substituted naphthoquinone as a tumor metabolic suppressor in vitro and in vivo

Ning, X., Li, Y., Qi, H., Li, R., Jin, Y., Liu, J., & Yin, Y. (2018) · MedChemComm · doi:10.1039/c8md00062j · Cited by 7 · see citing works

Depleted hexokinase1 and lack of AMPKα activation favor OXPHOS-dependent energetics in retinoblastoma tumors

Babu, V. S., Mallipatna, A. C., Dudeja, G., Shetty, R., Nair, A. P., Tun, S. B. B., Ho, C. E. H., Chaurasia, S. S., Bhattacharya, S. S., Verma, N. K., et al. (2023) · Translational research · doi:10.1016/j.trsl.2023.07.001 · Cited by 7 · see citing works

The distinct roles of ROS in tumor immunity: from mechanisms to immunotherapeutic applications

Li, J., Huang, C., Tang, P., Wu, R., Wu, Q., & Zhang, C. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01780-z · Cited by 34 · see citing works

Cancer dormancy and metabolism: From molecular insights to translational opportunities

Wang, Y., Liu, L., Zhang, X., Liang, T., & Bai, X. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218097 · Cited by 16 · see citing works

Mitochondrial metabolism in cancer stem cells (CSCs): molecular and diagnostic implications

Psvv, C., Sunil, S., Thuyyath, N., Kokkanti, R. R., & Lavudi, K. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1741800 · Cited by 12 · see citing works

Omega-3 fatty acid DHA induces ferroptosis in colorectal cancer patient-derived organoids and drug-tolerant cells

di Blasio, L., Vara-Messler, M., Peracino, B., Masti, E., Cepas, V., Trusolino, L., Puliafito, A., Bertotti, A., Monica, V., & Primo, L. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08744-8 · Cited by 12 · see citing works

Reprogramming the immunosuppressive breast cancer microenvironment: integrating cellular, metabolic, and stromal targets for rational immunotherapy

Ma, C., Teoh, H. K., Zhao, Y., Wang, Y., Zhao, J., Liu, Y., Zhao, C., & Ong, H. T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1760782 · Cited by 7 · see citing works

Dysregulation of the Cyclin D/E2F activity as a core mechanism driving cancer stem cell plasticity and cell cycle dynamics

Ahmadi, Y., Mohammed, T., Abolhasani, S., Hamad, S. A., & Faiq, T. (2025) · Cell Cycle · doi:10.1080/15384101.2025.2599081 · Cited by 6 · see citing works

Hydrogen sulfide-based nanotheranostics: A multifunctional platform for cancer diagnosis and therapy

Ran, W., Yan, Z. H. A. O., Huang, R., Cao, E., Zhou, J., Yu, J., Liu, H., & Wang, Y. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.174366 · Cited by 5 · see citing works

The symbiotic axis between the acidic tumor microenvironment and cancer stem cells: a driver of malignancy and therapeutic resistance

汪正宇, Yuan, H., Liu, M., Yuan, J., & Chen, D. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1804379 · Cited by 4 · see citing works

The evolving role of alternative splicing in cancer stem cell plasticity: From mechanisms to clinical opportunities

Tarmizi, M. D. A., & Ramasamy, T. S. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105020 · Cited by 4 · see citing works

Cancer stem cells and drug resistance in cancer: molecular mechanisms and therapeutic targets

Hamdy, H., 李有洲, Li, C. J., Li, Z., Liu, X. W., Sun, E., Safwat, D., Shen, J., Li, H., & Sun, J. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00516-2 · Cited by 4 · see citing works

Engineering the tumor microenvironment: oncolytic NDV to facilitate CAR-T cell therapy

Wang, M., Jiang, K., Aicher, A., & Heeschen, C. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07342-0 · Cited by 3 · see citing works

Investigating interspecies mitochondrial transplantation on the malignancy of melanoma cells

Kuo, F.-C., Cheng, B.-L., Tsai, C.-C., Chen, P. Y., Sung, W., Tsai, K.-J., Tsai, H.-Y., Huang, Y., Liu, C. K., Wu, D.-C., et al. (2026) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbag004 · Cited by 3 · see citing works

Metabolomic Insights into Head and Neck Cancer: Recent Advances and Future Directions

Ponneganti, S., Lavudi, K., Thalla, M., Narkhede, G., Dwivedi, R., Kokkanti, R. R., & PANDEY, P. (2026) · Current Oncology · doi:10.3390/curroncol33040201 · Cited by 3 · see citing works

The metabolic profiles of cancer stem cells

Tylichová, Z., Vojtěšek, B., & Coates, P. J. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-05014-4 · Cited by 3 · see citing works

The Warburg effect and beyond: Glycolytic reprogramming in cancer progression and emerging therapeutic strategies

Long, Y., Xu, J., Xu, Z., Su, Z., Li, W., & Li, J. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119692 · Cited by 3 · see citing works

Darunavir analog precursors target mitochondrial metabolism in multiple myeloma and CLL.

Mecca, M., Sichetti, M., Spina, E. L., Giuseffi, M., Giglio, E., Picerno, S., Valvano, L., Statuto, T., Santarsiere, A., Funicello, M., et al. (2025) · Cancer Cell International · doi:10.1186/s12935-025-04142-w · Cited by 2 · see citing works

Metabolic rewiring of the tumor microenvironment: therapeutic intervention of multi-pathway adaptations to impede cancer metastasis

Kaushik, K., Singh, H., Jha, K., Singh, R. P., & Kaur, N. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1792455 · Cited by 2 · see citing works

Targeting colorectal cancer stem-like cells: Overcoming therapeutic resistance and reprogramming the immunosuppressive niche.

Hamid, M., Siddig, A., Suliman, R., Saeed, A., Mussa, A., & Al-Hatamleh, M. A. I. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218665 · Cited by 2 · see citing works

Mitochondrial epigenetic mechanisms in cancer: an updated overview

Stoccoro, A., & Coppedè, F. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1720652 · Cited by 1 · see citing works

Targeting metabolic vulnerabilities with advanced delivery systems

Ye, W., Li, X., Chandra, J., Yu, J., Zhou, T., & Li, Z. (2026) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2026.01.003 · Cited by 1 · see citing works

Metabolic Landscape and Emerging Therapeutic Potential in Pediatric and Adult Gliomas

Brock, C. S., Nguyen, L., Pattillo, C., Ahamed, C., Sato, K., & Kumar, K. K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062720 · Cited by 1 · see citing works

Charting the molecular landscape of cancer: from genomic chaos to epigenetic control and energetic adaptation

Aziz, H. S., Mohammed, N. A. R., Abdulhameed, Y. H., & Ayad, A. (2026) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-026-00852-6 · Cited by 1 · see citing works

Integrating multi-omics data for next-generation cancer research and precision medicine

Biswas, S., Acharya, S., Prajapat, A., Sen, P., Desai, S., Giri, S., Matthiesen, R., CAPCI, T., Chaubey, G., & Suravajhala, P. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04368-8 · Cited by 1 · see citing works

Targeting Glycolytic Plasticity to Overcome Therapy Resistance in Cancer Stem Cells: Mechanisms and Clinical Perspectives

Huang, J. Z., Yang, X., Li, F., Li, X., Wei, H., & Li, M. Q. (2026) · Cells · doi:10.3390/cells15121107 · Cited by 1 · see citing works

Post-translational modifications as hubs of amino acid metabolism in cancer: From oncogenic signaling to therapeutic targeting

Xu, N., Shao, J., Jiang, L., Zhao, H., & Zheng, W. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189653 · Cited by 1 · see citing works

Targeting long non-coding RNA H19 attenuates PKM2 deficiency-driven stemness property in tongue cancer

Sun, W., Peng, T., Hsieh, R.-M., Yang, J.-W., Tang, Y.-W., & Sun, K.-H. (2026) · Biomedical Journal · doi:10.1016/j.bj.2026.101016 · Cited by 1 · see citing works

Amplification-Driven S100A11 Overexpression in Hepatocellular Carcinoma Is Associated with Metabolic Reprogramming, ECM Remodelling, and Immune Evasion: A Pan-Cancer Genomic Study

Lutimba, S., & Aleem, E. A. (2026) · Cancers · doi:10.3390/cancers18172848 · Cited by 1 · see citing works

Nanomedicine design strategy for preferential elimination of cancer stem cells by targeted HIF-Warburg-immune evasion axis: Systematic review

Song, L., Wang, X., Wu, D., Li, G., 康明芹, Pan, Y., Sun, Y., Xu, M., Li, Y., Gao, Y., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.109657 · Cited by 1 · see citing works

Bioinformatics-based identification of glycolysis-related signatures associated with drug resistance and prognosis in lung adenocarcinoma

Zheng, Q., Liu, Y., Li, T., Zhang, X., Geng, Y., Chen, Z., Zhou, J., Fan, W., Wang, Y., Zhang, L., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1871582

Cancer As a Slack-Sharing System: Structural Tradeoffs in Tumor and HostPreprint

Muniz, J. E. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6177638

Glycolytic Reprogramming Mediated Tumor Radioresistance

赖, 铭. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.162740

MRPL42 Knockdown Suppresses the Malignant Functions of Hepatocellular Carcinoma by Regulating Oxidative Phosphorylation

Lv, J., Gan, F.-Y., Li, M., & Yin, Q.-J. (2026) · Current Medical Science · doi:10.1007/s11596-026-00176-x

Expression of glycolytic markers in cancer and stromal cells of treatment-naïve and neoadjuvantly treated pancreatic ductal adenocarcinoma

Holm, M. B., Dorg, L. T., Revheim, M.-E. R., Labori, K. J., & Verbeke, C. S. (2026) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-026-04478-2

The authors respond to feedback on Cancer Cell-Memory Macrophage Hybrid Theory for metastatic cancer cells

Wu, J., & Jiang, C. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1780597

Metabolic reprogramming and cisplatin resistance: the emerging role of Pyruvate Dehydrogenase Kinases (PDKs)

Shaheeda, A., & Kabekkodu, S. P. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02845-9

Rewiring Glycolysis in Cancer: From Tumor Initiation to Therapeutic Vulnerabilities

Sun, S., Jia, L., Yu, Y., Jeong, S.-J., Zhang, Y., Ryu, D., & Ta, G. (2026) · Cells · doi:10.3390/cells15090771

Transcriptomic Profiling Reveals Isoform-Specific Regulatory Roles of miR-196A and miR-196B in Colorectal Cancer Cells

Mo, J. S., Shin, D. S., & Han, Y.-H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093959

The resilient subset: cancer stem cells at the core of immunotherapy resistance

Gajón, J. A., Esperante, D., Ko, N., Jimenez-Miranda, A., Muñoz-Cruz, S., Fuentes‐Pananá, E. M., & Bonifaz, L. C. (2025) · Immunotherapy Advances · doi:10.1093/immadv/ltag006

Overweight status drives early tumor microenvironment reprogramming in pancreatic ductal adenocarcinoma: a cell-type-resolved Bayesian hierarchical modeling and interactome analysisPreprint

Viswanathan, A. (., Seby, J., & Harikumar, K. B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.14.721695

Case Report: Cutaneous niche-restricted malignant phenotypes in PTCL-NOS revealed by single-cell sequencing

张树成, Li, Z., Yang, L. Y., Sun, X., Qiao, M., & Si, X. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1827539

Amplification-Driven S100A11 Overexpression in Hepatocellular Carcinoma Is Linked to Metabolic Reprogramming, ECM Remodelling, and Immune Evasion: A Pan-Cancer Genomic StudyPreprint

Lutimba, S., & Aleem, E. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.15.732272

Histone acetyltransferase Kat2a regulates glioma stem cell differentiation via Hsp90aa1-dependent oxidative phosphorylation

Yang, M., Chen, X., Li, M., Yang, J., Zheng, H., Shi, S., Luo, Q., Liang, Y., Xu, L., Kalvakolanu, D. V., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118197

Natural Compounds as Network-Level Modulators of Cancer Stem Cell Plasticity

Valdivia, S., Riquelme, C. V., Torres, Á., Urrutia, I. B., Gaete, O., & Alarcón, S. (2026) · Sci · doi:10.3390/sci8070150

Unveiling the oncogenic role of PDK3 in head and neck squamous cell carcinoma, an integrative in silico and an in vitro approach

Shaheeda, A., Shetty, D. N., Suresh, P. S., Mascarenhas, R., & Kabekkodu, S. P. (2026) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2026.100768

Multi-omic Profiling of Recurrence Risk Across Breast Cancer SubtypesPreprint

Cruikshank, A. E., Chandra, P., Li, C. I., & Ha, G. (2026) · medRxiv · doi:10.64898/2026.07.10.26357777

Tumor Plasticity and Microenvironmental Crosstalk as Drivers of Metastasis and Therapy Resistance

Dagar, G., Dagar, M., Gupta, A., Surendranath, A., Das, S. K., Rehmani, M. U., Tanwar, M., Mirza, S., Macha, M. A., Akil, A. S. A.-S., et al. (2026) · MedComm · doi:10.1002/mco2.70836

Unravelling the nexus of non-coding RNAs in cancer stemness and therapeutic drug resistance

Chen, S., Dakal, T. C., Bhushan, R., Arya, D. K., Gogoi, B., Kumar, A., Schmidt‐Wolf, I. G. H., Sharma, A., & Chen, M. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1870002

Mitochondrial reprogramming as a central driver of pancreatic ductal adenocarcinoma

Hernandez, J. A., Abedejos, P., Lopez, K. D. F., Donado, A. B. L., Roque, M. D. A., Serranilla, K. Y. V., Seol, J. E., Flores, J., Garcia, M. V. F., Marquez, J. C., et al. (2026) · Mitochondrial Communications · doi:10.1016/j.mitoco.2026.07.001

Research and advances in TK1-mediated metabolic reprogramming in modulating the tumor immune microenvironment in hepatocellular carcinoma

Chai, H., Wu, L., & Li, M. (2026) · Discover Oncology · doi:10.1007/s12672-026-05666-x

Mechanistic insights into genomic basis of crosstalk between metabolic reprogramming and immune dysfunction in ovarian cancer

Patial, M., Kesari, K. K., & Kumar, D. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105540

Reconstruction of the competing endogenous RNA network regulating carbohydrate metabolism genes in breast cancer

Gharechahi, J. (2026) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2026.100207

BAM15 Enhances Regorafenib Cytotoxicity in a Canine Osteosarcoma Cell Model

Dolnicka, A., Marcinkowska, K. A., Obmińska‐Mrukowicz, B., Fosse, V., Raciborska, A., & Śmieszek, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209121

Mitochondria in health and disease: cellular powerhouses, signaling centers, and drivers of dysfunction

Akinkunmi, O. A., Araba, F. F., Adaeze, C. J., Adenle, V. A., Odeyemi, A. A., Akhigbe, T. M., & Akhigbe, R. E. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1929130

Metabolic and Inflammatory Risk Stratification in Resected Cholangiocarcinoma: A Retrospective Exploratory Analysis

Prajumwongs, P., Titapun, A., Thanasukarn, V., Jareanrat, A., Khuntikeo, N., Namwat, N., Klanrit, P., Wangwiwatsin, A., Chindaprasirt, J., Sa-Ngiamwibool, P., et al. (2026) · Medical Sciences · doi:10.3390/medsci14050525

Carrier-as-Prodrug Glycyrrhizic Acid Nanogel Co-Delivers Mannose and Glycyrrhetinic Acid for Metabolic-Ionic Cancer Therapy

Sun, B., Zhu, J., Yishan, A. S., Liang, B., Zou, C., Wang, C., Qi, Y., Xia, Y., Cui, D., Shen, Y., et al. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c10812

Mitochondrial DNA Mutations and Oxidative Phosphorylation Reprogramming in Colorectal Cancer and Breast Cancer: Systematic Review of Distinct Mitochondrial Mechanisms in Tumor Progressions

Mazhar, N., Khan, M. A., Majeed, A., & Zafar, K. (2026) · Al-Najam Journal of Medical and Life Sciences · doi:10.68041/anjmls.v1i1/08

Metabolic convergence of diabetes and prostate cancer: from dysglycemia to tumor microenvironment reprogramming

Mukherjee, A. G., Bharti, A. K., Mathew, D. M., Gopalakrishnan, A. V., & Nishu, S. (2026) · Mammalian Genome · doi:10.1007/s00335-026-10274-9

Metabolic plasticity in castration-resistant prostate cancer: reprogramming mechanisms and therapeutic opportunities

Lou, Y., Lou, Z., He, L., & Luo, J. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112885

Metabolites and cancer metastasis

Yang, S., Shi, S., Hou, J., Zhang, J., & Su, Z. (2026) · Oncogene · doi:10.1038/s41388-026-03930-6

Mitochondrial metabolic plasticity in cancer: hybrid bioenergetic states and translational targeting in surgical oncology

Chattopadhyay, D., Rajendran, R. L., Mubin, N., Tendulkar, D., Singh, T. D., Ghosh, S., Jha, S. K., Gangadaran, P., & Ahn, B. (2026) · Experimental Biology and Medicine · doi:10.3389/ebm.2026.11244

RNA modifications and metabolism in cancer: Mechanisms, cross-talk and therapeutic implications

Luo, X., Zuo, X., He, J., & Yi, P. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.102622

Metabolic reprogramming and plasticity in breast Cancer: Mechanisms driving tumor progression, metastasis, and therapeutic resistance

Yuan, J., Zhang, H., Huang, J., Wang, B., Wang, M., & Yang, L. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189733

Targeting ferroptosis in cancer: molecular mechanisms and emerging therapeutic strategies

Khaledi, M., Ahani, H., Tohid, F. R., Kazemi, F., Amirkhani, E., Daliri, Z., Yadegari, S., Moarefvand, K., Poureslamfar, B., Sameni, F., et al. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102825

Nano-engineered phytochemicals in cancer therapy: mechanistic insights into apoptosis, ferroptosis, tumor microenvironment modulation and drug resistance reversal

Sahu, P., Satapathy, T., Satapathy, A., & Satapathy, A. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02452-6

Dynamic changes in the metabolic network and signalling pathways of cancer stem cells in therapy resistance

Didamson, O. C., George, S., & Abrahamse, H. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189738

Investigating a Potential Link Between Metabolic-Neurotrophic Coupling in Breast Tumor Innervation in Bioengineered Models

Ala-Kokko, N., Gregory, E., Woessner, A. E., Guan, B., Middleton, W., Johann, D. J., Rajaram, N., Muldoon, T. J., & Song, Y. H. (2026) · Cells · doi:10.3390/cells15211959

Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy

Papadaki, S., & Magklara, A. (2022) · Cancers · doi:10.3390/cancers14235912 · Cited by 59 · see citing works

Metabolic adaptations in cancer stem cells: A key to therapy resistance

Masoudi, M., Moti, D., Masoudi, R., Auwal, A., Hossain, M. M., Pronoy, T. U. H., Rashel, K. M., Gopalan, V., & Islam, F. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167164 · Cited by 48 · see citing works

Targeting Glycolytic Plasticity to Overcome Therapy Resistance in Cancer Stem Cells: Mechanisms and Clinical Perspectives

Huang, J. Z., Yang, X., Li, F., Li, X., Wei, H., & Li, M. Q. (2026) · Cells · doi:10.3390/cells15121107 · Cited by 1 · see citing works

Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy

Kaur, J., & Bhattacharyya, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.756888 · Cited by 36 · see citing works

Cancer Stem Cell Metabolism and Potential Therapeutic Targets

Snyder, V., Reed-Newman, T. C., Arnold, L., Thomas, S. M., & Anant, S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00203 · Cited by 197 · see citing works